Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018226788) ANTI-ADAM33 OLIGONUCLEOTIDES AND RELATED METHODS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/226788 International Application No.: PCT/US2018/036203
Publication Date: 13.12.2018 International Filing Date: 06.06.2018
IPC:
A01K 67/027 (2006.01) ,C07K 14/705 (2006.01)
A HUMAN NECESSITIES
01
AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
K
ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
67
Rearing or breeding animals, not otherwise provided for; New breeds of animals
027
New breeds of vertebrates
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435
from animals; from humans
705
Receptors; Cell surface antigens; Cell surface determinants
Applicants:
UNIVERSITY OF MASSACHUSETTS [US/US]; One Beacon Street, 31st Floor Boston, MA 02108, US
UNIVERSITY OF SOUTHAMPTON [GB/GB]; University Road Southampton Hampshire SO17 1BJ, GB
Inventors:
WATTS, Jonathan; US
HAITCHI, Hans, Michael; GB
PENDERGRAFF, Hannah; DK
Agent:
VELEMA, James, H.; US
COUGHLIN, Sean, M.; US
WILKINS, Andrew, T.; US
XU, Lily; US
ANIS, Hissan; US
BARTON, Steven, K.; US
CHEN, Xiaoyue (Peter); US
CUSTER, Andrew, W.; US
DECONTI, Giulio, A.; US
DELANEY, Marie; US
DIZEREGA, Philip; US
JEFFRIES, James, H.; US
JOHNSON, Joseph; US
KNAPP, Jacquelyn, D.; US
LAMBRECHTS, Robert, J.; US
LINK, Douglas; US
POPLIN, Alan, J.; US
QUINN, Anna; US
SPELLBERG, Michael; US
STEELE, Alan; US
STONE-HULSLANDER, Judith; US
TEOFILO, Javier; US
TRINQUE, Brian, C.; US
VOCK, Curtis, A.; US
Priority Data:
62/516,31507.06.2017US
Title (EN) ANTI-ADAM33 OLIGONUCLEOTIDES AND RELATED METHODS
(FR) OLIGONUCLÉOTIDES ANTI-ADAM33 ET PROCÉDÉS ASSOCIÉS
Abstract:
(EN) The present disclosure provides antisense compounds, methods, and compositions for silencing ADAM33 mRNA. The present disclosure provides antisense compounds, methods, and compositions for the treatment, prevention, or amelioration of diseases, disorders, and conditions associated with ADAM33 in a subject in need thereof. Also contemplated are antisense compounds and methods for the preparation of a medicament for the treatment, prevention, or amelioration of a disease, disorder, or condition associated with ADAM33.
(FR) La présente invention concerne des composés anti-sens, des procédés et des compositions destinés à l'extinction de l'ARNm ADAM33. La présente invention concerne des composés anti-sens, des procédés et des compositions pour le traitement, la prévention ou l'amélioration de maladies, de troubles et d'états associés à ADAM33 chez un sujet en ayant besoin. L'invention concerne également des composés anti-sens et des procédés pour la préparation d'un médicament en vue du traitement, de la prévention ou de l'amélioration d'une maladie, d'un trouble ou d'un état associé à ADAM33.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)